| DWTX Shares Outstanding History Table | ||||||||||||||||
Below is a table of the DWTX shares outstanding history going back to 11/6/2024:
Also see: DWTX Market Cap History DWTX YTD Return |
As of 5/13/2026 Dogwood Therapeutics has 33.63 million DWTX shares outstanding. Investors often track the DWTX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows DWTX share count trends over time, with 7 historical shares outstanding datapoints presented, dating back to 11/6/2024.

| DWTX Shares Outstanding History Table | ||||||||||||||||
Below is a table of the DWTX shares outstanding history going back to 11/6/2024:
Also see: DWTX Market Cap History DWTX YTD Return |
| DWTX Shares Outstanding History Chart | |||||||||||||||||
DWTX Historical Shares Outstanding: +745.57% CAGR
Mouse over chart for data details
| |||||||||||||||||
| DWTX Stock Price Chart |
| About Dogwood Therapeutics Inc |
| Dogwood Therapeutics, Inc., formerly Virios Therapeutics, Inc., is focused on the clinical development of three assets, Halneuron, IMC-1, and IMC-2. Halneuron is in Phase 2b development as a non-opioid, Nav 1.7 inhibitor, to treat the neuropathic pain associated with chemotherapy treatment. Halneuron is an injectable formulation of Tetrodotoxin, a novel small molecule with action exclusively on the peripheral nervous system. IMC-2 (valacyclovir + celecoxib) is in Phase 2 development as a combination antiviral treatment for Long-COVID (LC). IMC-1 (famciclovir (FM) + celecoxib) is Phase 3 development ready as a combination antiviral treatment for FM. We show 7 historical shares outstanding datapoints in our coverage of DWTX's shares outstanding history. Understanding the changing numbers of DWTX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DWTX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DWTX by allowing them to research DWTX shares outstanding history as well as any other stock in our coverage universe. |
| DWTX Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| DWTX Share Performance |
| Shares Outstanding Peers |
| Dogwood Therapeutics (DWTX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
DXCM Shares Outstanding History DYAI Shares Outstanding History DYN Shares Outstanding History DYNT Shares Outstanding History EAR Shares Outstanding History EBS Shares Outstanding History ECOR Shares Outstanding History ECYT Shares Outstanding History EDAP Shares Outstanding History EDGE Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.